Chris Smith

Chris is a Senior Investment Manager with Brandon Capital Partners, Australia’s largest life-science VC, and manager of the Medical Research Commercialisation Fund (MRCF). He is on the boards of both drug and medical device companies. Before this, Chris was a Business Development Manager with CSL Ltd. Chris spent three years as a postdoctoral immunologist and virologist at The University of Cambridge, UK.

Chris has a first class honours degree in science from the University of Melbourne, a PhD in Immunology conducted at the Walter and Eliza Hall Institute, and an MBA specialising in innovation and entrepreneurship from the University of Cambridge.